Abstract  by unknown
426A ABSTRACTS – Poster JACC Febmary 1997
rate and veloeity were measured and fluid meehaniccdenergy losses were
calculated. Significant differences were found between the valvea in Certain
orientationa. In the Steady flow experiments, the mean 10ssfor all stroke
volumes was 0.75 Joules for the MH tilting disc valve and 1.03 for the SJM
bileaflet valve in their optimum orientations. The tilting disc valve had less
energy loss than the bileaflet valve at all stroke volumes (p -=0.05). Orienta-
tion within the annulus did notsignificantly affect the energylossesthrough
the SJM valve.
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Corrchsiorrs:In models of ventricular hypertrophy, there were a distinct
hemodynamic advantages in using a specific mechanical valve in its optimal
orientation. For the most severe cases of hypertrophy,the MH valve showed
both the best and worst hemodynamic profile, depending on its orientation
within the annulus.
~42-1161 C-MycExpressionRelatestoReversalof
VentricularFunctionandHypertrophyin Patiente
withAorticVaiveReplacement
S. Taketeni, Y. Sawa, K. Kadoba, H. Imagawa, H. Ichikewa, H. Mafauda. fst
Oeptof Surg,OeakaUnh, Osaka,Japan
In most patients with aortic regurgitation (AR), valve replacement results
in reduction in left ventricular dilatation and in increase in ventricular func-
tion. However, its mechanism is undetermined.Recently,we reported that
proto-oncogene C-MYCis related to extensive cardiac hypertrophy and left
ventricular funetion in patients with chronic AR. However, it has not been clar-
ified whether C-MYCrelate to reversal of left ventricular function and cardiac
hypertrophy after Aortic vaive replacement (AVR). This study is designed
to clarify the relationship among the C-MYCexpression, cardiac hypertrophy
and ventricular function in patienta with AR underwent AVR. Four patients
(2 male and 2 female, 52 to 73 yeare old mean; 65 + 12) with isolated
chronic AR who undetwent aortic valve replacement were included in this
study. Preoperative NYHA class was II in 2 patients, Ill in 2. Left ventricular
ejection fraction (EF), Ieftventricular end-systolic volume index (LVESVI)and
Ieftventricular mass index (LVMI) before operation were obtained before and
a mean of 36 months after AVR. Left ventricular endomyoeerdial biopsy was
performed to assess the myocerdial cell diameter (CD), fibrous content (FC),
and immunohistochemicel staining of C-MYC.After AVR, patients showad
significantly lower value in ESVI (42.5 l 14.4 vs 32.5 + 13.6 ml/m2), LVMI
(167.7 + 34.3 va 126.7 + 27.5 g/m2), CD (26.1 + 9.6 vs 24.1 * 9.6 Mm)
than those before AVR. However, there were no differ in EF (71.7 * 6.1 vs
69.7 & 11.3%) and EDVI (119.7* 26.6 vs 92.5 * 19.6 g/n_?)and FC (26.5
+ 13.2 vs 23.4 + 10.4 @m*). These patients showed C-MYCexpression in
more than half nuclei of myoeytes (66.3 + 16.1%) while it has not been
detected in normal Control. Moreover, these C-MYCexpression significantly
deereasad after AVR (10.1 + 6.1%) than before AVR. In summary, C-MYC
was expressed in the volume overloading hearI and deereases in reversal of
ventricular function after AVR, suggesting that C-MYCexpression may relate
to reversal ventricular function and cardiac hypertrophy in patients with after
AVR.
m1042117 Evoiutionof LeftandRightVentricularFunctionAfterSurgicalCorrectionof Severs,non
ischemicMitralRegurgitation
T. Le Toumeau, P.de Groote, C. Foucher, A. Millaire, H. Waremtmurg,
J.-M. Leblanche, G. DtJcloux.UniversifyofLine,Li//e,France
Preaewation of heart function is an important goal of aurgieal correction
of mitral valve (MV) regurgitation. We studied the evolution of global and
regional left ventricular (LV) and right ventricular (RV) ejection fraction (EF)
in 39 consecutive pts (59 + 12 years) after surgical corraefion of mitral
regurgitation. Radionuclide angiography was performed beforeand 7 months
(217 +60 days) after either MV repair (n = 23) or replacement with posterior
chordal preservation (MVR, n = 16). LVand RV EF were not different in the 2
groups before surge~. For all the pts, LVEF decreased (64.6& 10.1 to 60.1
+ 11.4%, p = 0.032) and RVEF increaaed (41.7 + 9.5 to 44.9 + 9.5%, p =
0.04) after surgety. However, LVEF decreased significantly after MVR (64.1
+ 6.5 to 57.4 + 10%, p = 0.01) but not after MV repair (65 4Z11.3 to 62.1 A
12.2%,p= NS), and RVEFwas unchanged after MVR (42.9 + 10.3 t042.8 +
6.6%) but increased after MV repair (40.9+ 9.1 to 46.4+ 10.1%, p = 0.03).
Moreover, there was a significant reduction in contraction in LV aegmenfe 4
and 5 (apex and lateral wall) after MVR (Fig).
Thus, the evolution of heart function is batter after MV repair than after
MVR for mitral regurgitation.
-1 FIOXiblOVO.Ri~id Ring AnnUIOpiaa~: A Finite
ElementModel
K.S. Kunzelman, M. Reimink, R.P.Cochran. UrriveraityofkVaahington,
Seatfle,WA,USA
Purpose:A 3-D finite element computer model was used to compare leaflet
stressesand coaptation in normal and dilated valvea (18% annular dilatation)
vs. valves with flexible (Duran) and rigid (Carpentier-Edwards classic) ring
annuloplasty. Methods:The rings and valves were aimulated using ANSYS
4.4A software. Valves were evaluated during systolic pressure loading (peak
= 120 mmHg), and leaflet stresses and time to coaptetion were determined.
Resu/fs: In the normal valve, the anterior leaflet was subject to higher tensile
stresses than the posterior leaflet which was under compre~ion. Annular
dilatation increased all stresses, particularly intheposterior Ieafletsandatthe
tngones. Both rings returned the posterior leaflet stresses towards normal.
The flexible ring returned anterior leaflet stress closer to normal than the
rigid ring. Leaflet coaptation began at 5 ms in the normal state, was delayed
by dilatation, and returned towards normal with both rings. Conchsions:
Ring annuloplasty reduces the stresses and improves coeptetion relative to
annular dilatation. The success of mitral annuloplasty is likely due to the
reestablishment of posterior leaflet eompresaive stresses and near normal
coeptation.
Streaaranges(kPe)in leaflets,andtimetocoarMation(me),
CentralAnterior TrigoneArea PoeteriorLeaflet llme atcoaptetion
Normal loo-4to 400-531 –S-225 5
Dilatation f50-580 820-1390 –s-435 45
Flexiblering 100-420 400-503
Rigidring
–8-230 5
150-570 70C-1203 –S-240 10
11042-119I OptimizedOralAnticoaguiationby PatientPT
SslfMonitoringandSelfManagement
A. Bernardo. Herz-Kreialauf-klirrik,BadBerlebug,Germany
Epidemiologic evidence indicates that thromboembolism and antieoagulant-
related hemorrhage remain the major complications after heart valve re-
placement. This study assesses a new model of anticoagulant management,
with regard to the feasibility and ability, and also the safety and effieaey of
patient managed oral anticoagulation with the help of a portable PT monitor.
This investigation is a retrospective, non-randomised study with 351 patients
on long-term anticoagulation. The study started for the first time in August
1986.The mean follow up is 26 months (3to 102 months). The study patients
reported a total of 26359 self-monitored INR’s. In the recommended target
range (INR 2.54.5) were 23264 INR’s (62%), above the target range (INR
> 4.5) were 679 INR’s (2.4%) and below the target range (INR < 2.5) were 4
416 INR’s (15.6%). On average the patients measured their INR at a weekly
interval. During 834.4 patient-years slight bleedings occurad in 64 patients
(7.7 per 100 petient-yeara), bleeding mmplicetions requiring medical treat-
ment in 10 patients (1.2 per 100 patient-years) and thromboembolic episcdes
with transient symptoms in 4 patients (0.5 per 100 patient-years).
Patient self management of oral anticoagulation leads to improved an-
ticoegulation care and to reducedrisk of hemorrhagic or thromboemlwtic
complications.
